@article{UBHD-68421099,
  author={Haag, Georg Martin and Z{\"o}rnig, Inka and Hassel, Jessica C. and Halama, Niels and Dick, Julika and Lang, Nina and Podola, Lilli and Ziegelmeier, Claudia and Freitag, Angelika and Beckhove, Philipp and Enk, Alexander and J{\"a}ger, Dirk},
  title={Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1},
  year={2018},
  pages={122-129},
  language={eng},
  issn={1879-0852},
  volume={90},
  note={Gesehen am 15.08.2019},
  journal={European journal of cancer},
  doi={10.1016/j.ejca.2017.12.001},
}
@article{UBHD-68262742,
  author={Schmitz-Winnenthal, Friedrich Hubertus and Hohmann, Nicolas and Friedrich, Tobias and Mikus, Gerd and Weitz, J{\"u}rgen and Ulrich, Alexis and B{\"u}chler, Markus W. and Pianka, Frank and Klaiber, Ulla and Diener, Markus K. and Leowardi-Bauer, Christine and Schimmack, Simon and Peters, Leila and Springfeld, Christoph and Knebel, Phillip and Schmidt, Thomas and Ge, Yingzi and Stamova, Slava and Podola, Lilli and Haefeli, Walter E. and Grenacher, Lars and Beckhove, Philipp},
  title={Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer},
  subtitle={a randomized, placebo-controlled, phase 1 trial},
  year={2015},
  pages={13 S.},
  language={eng},
  issn={2162-402X},
  volume={4(2015},
  note={Gesehen am 01.12.2016},
  journal={OncoImmunology},
  doi={10.1080/2162402X.2014.1001217},
}